04/03/2024: Climate Change and Human Health: An Alaska Perspective

Climate Change and Human Health: An Alaska Perspective

About the webinar:

Temperatures are rising 2 to 3 times faster in Alaska and throughout the circumpolar regions as a result of climate change. This presentation will explore the wide range of climate change’s impacts on the Alaskan ecosystem and address some of its impacts on the health of Alaskan people.

Learning Objectives

At the completion of this activity, the learner will be able to:

  • Describe how climate change is impacting Alaska’s ecosystem

  • Identify how marginalized populations are experiencing the greatest impact on their ways of living
  • Discuss how these changes have a domino effect resulting in direct and indirect impacts on human health

Speaker: Jeffrey G. Demain, MD, FAAAAI, FACAAI, FAAP

Dr. Jeffrey G. Demain is the founder of the Allergy, Asthma & Immunology Center of Alaska. He is co-owner and medical director of Lux Infusion & Lux Immunology. He is a Clinical Professor at the University of Washington, Department of Pediatrics, and an Affiliate Professor at the University of Alaska, WWAMI School of Medical Education. He is board certified in adult and pediatric allergy and immunology. Dr Demain serves on the board of regents of the American College of Allergy, Asthma & Immunology and serves on the board of directors of the American Board of Allergy Immunology. Dr Demain has lived in Alaska for 30 years, where he has witnessed and researched the environmental impacts of climate change. A nationally recognized speaker, Dr. Demain has published over 50 peer-reviewed publications and has authored four textbook chapters.

Certificates of Completion

Certificates of Completion will be available to webinar participants who are present for the complete, live webinar, and logged in with their registered email address. Call-in attendees are not eligible for certificates at this time - Please download the Zoom app to log in via email on your smartphone whenever possible.

In order to receive your Certificate of Completion, qualified learners must complete the post-webinar evaluation within 7 days of the webinar. A link to the evaluation will be emailed to qualified learners 24 hours after the webinar via no-reply@zoom.us. Qualified learners who submit their evaluation will receive a Certificate of Completion via email, and can also print/save the certificate from their browser after submitting their evaluation.

If you're not able to attend the live presentation, no problem! We record most presentations and will host them on our website provided we have permission to do so. Presentation recordings are not eligible for Certificates of Completion.

ACCESSIBILITY:

If you require an accommodation for effective communication (ASL interpreting/CART captioning, alternative media formats, etc.) to fully participate in this event, please contact Michelle Meyer at (510) 642-8365 or mmeyer@berkeley.edu(link sends e-mail) with as much advance notice as possible and at least 7-10 days in advance of the event.

ACCREDITATION

The Center for Occupational and Environmental Health designates this activity for a maximum of 1.5 Contact Hours. Participants should claim only the credit commensurate with the extent of their participation.

The Center for Occupational and Environmental Health is accredited by the California Medical Association to provide continuing medical education for physicians.

The Center for Occupational and Environmental Health designates this live activity for a maximum of 1.5 AMA PRA Category 1 Credit(s)™.

Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Provider approved by the California Board of Registered Nursing, Provider Number 12983, for 1.5 contact hours.

Disclosure

Jeffrey G Demain, MD, FAAAAI, FACAAI, FAAP, serves as a consultant and on the Speaker Bureau for Blueprint Medicine. No other individuals involved in the planning or presentation of this activity have any relevant financial relationships with commercial interests to disclose. All of the relevant financial relationships listed have been mitigated.